An experimental comparative study on the characteristics of ventricular fibrillation during cardiac arrest and methoxamine administration

J Tongji Med Univ. 1997;17(2):94-7. doi: 10.1007/BF02888243.

Abstract

The effect of a pure alpha-adrenergic agent, methoxamine on ventricular fibrillation (VF) amplitude and the relation between hemodynamic parameters and survival in a rodent cardiopulmonary resuscitation (CPR) model were studied. Our results suggested that: 1) VF amplitude decreased during untreated VF, but it increased during pericardial chest compression: 2) methoxamine significantly increased the mean aortic pressure (MAP) and coronary perfusion pressure (CPP) but not VF amplitude, and the survival also increased due to elevation of CPP; and 3) all surviving animals with successful defibrillation had a higher VF amplitude.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology*
  • Animals
  • Cardiopulmonary Resuscitation
  • Electric Countershock
  • Heart Arrest / physiopathology*
  • Male
  • Methoxamine / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Ventricular Fibrillation / physiopathology*

Substances

  • Adrenergic alpha-Agonists
  • Methoxamine